$PRAX ($PRAX) posted quarterly earnings results for Q1 2026 on Thursday, May 7th. The company reported earnings of -$3.20 per share, beating estimates of -$3.64 by $0.44. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $PRAX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
$PRAX Insider Trading Activity
$PRAX insiders have traded $PRAX stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $PRAX stock by insiders over the last 6 months:
- ALEX NEMIROFF (General Counsel and Secretary) has made 0 purchases and 4 sales selling 25,130 shares for an estimated $4,852,255.
- LAUREN MASTROCOLA (Principal Accounting Officer) has made 0 purchases and 2 sales selling 13,600 shares for an estimated $2,612,243.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
$PRAX Hedge Fund Activity
We have seen 192 institutional investors add shares of $PRAX stock to their portfolio, and 77 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 1,315,464 shares (+3044.3%) to their portfolio in Q4 2025, for an estimated $387,719,859
- ORBIS ALLAN GRAY LTD added 1,255,162 shares (+inf%) to their portfolio in Q4 2025, for an estimated $369,946,447
- POINT72 ASSET MANAGEMENT, L.P. removed 1,003,640 shares (-67.1%) from their portfolio in Q4 2025, for an estimated $295,812,853
- SOLEUS CAPITAL MANAGEMENT, L.P. removed 496,200 shares (-57.8%) from their portfolio in Q4 2025, for an estimated $146,249,988
- JANUS HENDERSON GROUP PLC added 476,227 shares (+17.2%) to their portfolio in Q4 2025, for an estimated $140,363,145
- BARCLAYS PLC added 454,114 shares (+592.6%) to their portfolio in Q4 2025, for an estimated $133,845,560
- BAKER BROS. ADVISORS LP added 437,000 shares (+63.4%) to their portfolio in Q4 2025, for an estimated $128,801,380
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
$PRAX Analyst Ratings
Wall Street analysts have issued reports on $PRAX in the last several months. We have seen 6 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 02/04/2026
- Piper Sandler issued a "Overweight" rating on 01/28/2026
- Guggenheim issued a "Buy" rating on 12/09/2025
- Jefferies issued a "Buy" rating on 12/09/2025
- BTIG issued a "Buy" rating on 12/08/2025
- Wedbush issued a "Underperform" rating on 12/05/2025
- HC Wainwright & Co. issued a "Buy" rating on 12/05/2025
To track analyst ratings and price targets for $PRAX, check out Quiver Quantitative's $PRAX forecast page.
$PRAX Price Targets
Multiple analysts have issued price targets for $PRAX recently. We have seen 13 analysts offer price targets for $PRAX in the last 6 months, with a median target of $510.0.
Here are some recent targets:
- Ami Fadia from Needham set a target price of $510.0 on 04/14/2026
- Douglas Tsao from HC Wainwright & Co. set a target price of $1245.0 on 04/07/2026
- Kambiz Yazdi from BTIG set a target price of $843.0 on 04/06/2026
- Rudy Li from Wolfe Research set a target price of $500.0 on 02/24/2026
- Laura Chico from Wedbush set a target price of $130.0 on 02/20/2026
- Joon Lee from Truist Securities set a target price of $700.0 on 02/20/2026
- Benjamin Burnett from Wells Fargo set a target price of $305.0 on 02/20/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.